These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11363024)

  • 41. Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma: successful treatment with interferon-alpha.
    Ueno T; Mitsuishi T; Kimura Y; Kato T; Hasegawa H; Katano H; Sata T; Kurane S; Kawana S
    Eur J Dermatol; 2007; 17(6):539-40. PubMed ID: 17951139
    [No Abstract]   [Full Text] [Related]  

  • 42. Thalidomide in the treatment of Kaposi's sarcoma.
    Rubegni P; Sbano P; De Aloe G; Flori ML; Fimiani M
    Dermatology; 2007; 215(3):240-4. PubMed ID: 17823523
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of AIDS-related Kaposi's sarcoma: advances in target discovery and treatment.
    Dezube BJ
    Expert Rev Anticancer Ther; 2002 Apr; 2(2):193-200. PubMed ID: 12113241
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is combination antiviral therapy for CMV superior to monotherapy?
    Drew WL
    J Clin Virol; 2006 Apr; 35(4):485-8. PubMed ID: 16387546
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatments of AIDS-related Kaposi's sarcoma.
    Aversa SM; Cattelan AM; Salvagno L; Crivellari G; Banna G; Trevenzoli M; Chiarion-Sileni V; Monfardini S
    Crit Rev Oncol Hematol; 2005 Mar; 53(3):253-65. PubMed ID: 15718150
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Infection with human herpesvirus type 8 and Kaposi's sarcoma in Sardinia.
    Serraino D; Cerimele D; Piselli P; Aztori L; Farchi F; Carletti F; Navarra A; Masala MV; Rezza G
    Infection; 2006 Feb; 34(1):39-42. PubMed ID: 16501902
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Infection with human herpesvirus type 8 and kaposi's sarcoma in a central Italian area formerly endemic for malaria.
    Serraino D; Corona RM; Giuliani M; Farchi F; Sarmati L; Uccella I; Andreoni M; Rezza G
    Infection; 2003 Jan; 31(1):47-50. PubMed ID: 12590333
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Natural killer cells are not infected by Kaposi's sarcoma-associated herpesvirus in vivo, and natural killer cell counts do not correlate with the risk of developing Kaposi's sarcoma.
    Stebbing J; Gazzard B; Flore O; Thomas C; Benlahrech A; Mandalia S; Bower M; Gotch F; Patterson S
    AIDS; 2003 Sep; 17(13):1998-2000. PubMed ID: 12960839
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human herpesvirus-8 infection and Kaposi's sarcoma after liver and kidney transplantation in different geographical areas of Spain.
    García-Astudillo LA; Leyva-Cobián F
    Transpl Immunol; 2006 Dec; 17(1):65-9. PubMed ID: 17157220
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy.
    Cattelan AM; Calabrò ML; De Rossi A; Aversa SM; Barbierato M; Trevenzoli M; Gasperini P; Zanchetta M; Cadrobbi P; Monfardini S; Chieco-Bianchi L
    Int J Oncol; 2005 Sep; 27(3):779-85. PubMed ID: 16077928
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sirolimus for Kaposi's sarcoma.
    Wasywich CA; Croxson MC; van Doornum GJ; Coverdale HA; Ruygrok PN
    J Heart Lung Transplant; 2006 Jun; 25(6):726-9. PubMed ID: 16730579
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
    de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
    J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monitoring of endogenous interferon-alpha and human herpesvirus 8 in HIV-infected patients with Kaposi's sarcoma.
    Plettenberg A; Albrecht D; Lorenzen T; Meyer T; Arndt R; Stoehr A
    Eur J Med Res; 2002 Jan; 7(1):19-24. PubMed ID: 11827836
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of Kaposi's sarcoma in resource-limited settings in the era of HAART.
    Lynen L; Zolfo M; Huyst V; Louis F; Barnardt P; Van de Velde A; De Schacht C; Colebunders R
    AIDS Rev; 2005; 7(1):13-21. PubMed ID: 15875657
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CMV resistance: "more complicated than we thought".
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1996 May; 2(5):37-9. PubMed ID: 11363529
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regression of post-transplant Kaposi's sarcoma using sirolimus.
    Kolhe N; Mamode N; Van der Walt J; Pattison J
    Int J Clin Pract; 2006 Nov; 60(11):1509-12. PubMed ID: 16787440
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.
    Reddy AJ; Zaas AK; Hanson KE; Palmer SM
    J Heart Lung Transplant; 2007 Dec; 26(12):1286-92. PubMed ID: 18096480
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Severe renal failure and polyneuritis induced by foscarnet.
    Chatelain E; Deminière C; Lacut JY; Potaux L
    Nephrol Dial Transplant; 1998 Sep; 13(9):2368-9. PubMed ID: 9761526
    [No Abstract]   [Full Text] [Related]  

  • 59. Acyclovir.
    Koym S
    J Kans Med Soc; 1982 Jun; 83(6):307. PubMed ID: 6286813
    [No Abstract]   [Full Text] [Related]  

  • 60. Herpesvirus disease: an update.
    Nadler JP; Busciglio LA
    Compr Ther; 1997 Feb; 23(2):104-7. PubMed ID: 9083720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.